Gastrointestinal Diseases Clinical Trial
Official title:
A Randomized Comparison of UnderwateR Versus Regular Coagulation in Endoscopic Submucosal DissectioN and Third Space Endoscopy
What the investigatorpropose in this protocol is a technique already used in clinical practice. It prevents the risk of bleeding and make third space endoscopy easier, quicker, safer and cheaper. Indeed, we noticed that preventive underwater coagulation of the candidate vessels during the submucosal dissection with the Hybrid Knife (HK), seal the wall of the vessel, resulting in a subsequent cut under CO2 without any bleeding. Such preventive coagulation is likely to be related with the conduction of the current underwater as it focalizes all the power on the interface between the vessel and the water, allowing a soft sealing of the vessel without cutting it. Despite widely used, there is no evidence up to know on the benefit and harm of such coagulation technique. The hypothesis is that the use of this approach in clinical practice, especially when used to coagulate a vessel, may lead to an increase in safety, feasibility and cost-effectiveness, reducing the procedural time, the rate of complications and the need for coagulation forceps in comparison with the conventional preventive coagulation technique under CO2 insufflation. Therefore, this randomized study compares the underwater coagulation technique with the conventional coagulation technique in the CO2 setting during the submucosal dissection in third space endoscopy.
POEM will be performed under general anaesthesia in the supine position. The location of the esophagogastric junction (EGJ) will be identified and, then, after submucosal injection of saline mixed with methylene blue, a 2-cm mucosal incision carried out at 5-6 o'clock position about 10 cm above the EGJ. After, a dissection of the underlying submucosa will be performed to access the submucosal space. Then, the dissection of the submucosal layer will be continued to create the submucosal tunnel down to the narrower submucosal space at the EGJ and 2-3 cm into the cardia. During the submucosal tunnelling, coagulation of vessels will be performed with HK using SWIFT COAG E3, 89 W in the underwater setting in the treatment arm or with the standard technique in the CO2-setting in the conventional group. After, the myotomy of the circular muscular layer will be performed from 2-3 cm below the mucosal incision until 2-3 cm below the EGJ in both groups. In some cases, a full thickness myotomy, including the longitudinal muscular layer, will be carried out. Finally, complete closure of the mucosal entry site will be achieved with haemostatic clips. The procedure time, the number of instrument exchanges and bleeding episodes requiring the use of coagulation forceps during the procedure will be documented from start of submucosal tunnelling until final clip closure in both groups. Fujifilm high-definition gastroscopes (Fujifilm Co., Tokyo, Japan) with a 2.8-mm operative channel and a transparent distal cap attachment will be used in both groups. A submucosal lift with saline mixed with methylene blue through a 23 G injection needle will be accomplished for the mucosal entry. POEM will be carried out using a HK (Erbe Elektromedizin GmbH, Tübingen) in both groups. This instrument has an outer diameter of 2.1 mm and an inner diameter of 1.2 mm with both electrosurgical and water-jet (WJ) surgery technologies in one device. The HK combines needle-less submucosal injection, cutting, dissection and coagulation in one instrument. The modular VIO generator (VIO 3, Erbe Elektromedizin GmbH, Tübingen, Germany) will be used as an electrosurgical system in combination with the ERBEJet 2 WJ surgery system in both groups. A slightly methylene blue-stained isotonic saline solution will be used for submucosal injection with the WJ technique in both groups. Mucosal incision and myotomy will be carried out using ENDO CUT Q 2-3-3 and ENDO CUT Q 2-3-3, respectively, in both groups. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02541357 -
Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
|
N/A | |
Active, not recruiting |
NCT02358122 -
Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh
|
N/A | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Enrolling by invitation |
NCT00943345 -
Validation of New Tests for Gastrointestinal (GI) Permeability
|
Phase 0 | |
Completed |
NCT00612404 -
Symptoms and Endoscopic Results in Consideration of Pretreatment
|
N/A | |
Completed |
NCT01127711 -
Cohort of Swedish Men
|
N/A | |
Recruiting |
NCT05712525 -
Gut Recovery In Patients Following Surgery
|
||
Recruiting |
NCT06094153 -
Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
|
N/A | |
Recruiting |
NCT05322486 -
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
|
||
Completed |
NCT02486146 -
GI Biorepository of Tissue and Bodily Fluids
|
N/A | |
Completed |
NCT01816607 -
Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
|
||
Completed |
NCT00247715 -
Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)
|
N/A | |
Completed |
NCT00035334 -
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT06286865 -
Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial
|
N/A | |
Active, not recruiting |
NCT01037049 -
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
|
Phase 2 | |
Completed |
NCT03725813 -
Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit
|
N/A | |
Recruiting |
NCT05640401 -
Holographic Screens as a Replacement of Monitors During GI Endoscopies
|
N/A | |
Completed |
NCT02865564 -
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
|
N/A | |
Completed |
NCT02651857 -
Exploratory Study of Upper and Lower Endoscopic Fuse System
|
N/A | |
Active, not recruiting |
NCT01984034 -
Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines
|
N/A |